良性孤立性神经鞘瘤的PET/CT与增强CT影像表现
回顾性分析58例经手术或活检证实的良性孤立性神经鞘瘤的PET/CT、增强CT及病理资料,评估各变量与SUVmax的关联。结果显示肿瘤位于胃肠道/心脏/腹盆腔/胸壁、存在瘤周淋巴细胞套及中至显著强化与高FDG摄取显著相关,准确认识这些因素有助于降低误诊率。
要点
- 良性孤立性神经鞘瘤SUVmax为4.1±2.1(范围1.5-11.1),可表现为高FDG摄取。
- 位于胃肠道/心脏/腹盆腔/胸壁者SUVmax 5.8±2.4,高于其他部位3.3±1.5(p=0.000)。
- 瘤周淋巴细胞套与局部淋巴结增大相关,7例中5例伴瘤周淋巴结增大。
核心结论
- 起源于胃肠道/心脏/腹部、伴瘤周淋巴细胞套或增强CT示中至显著强化的良性神经鞘瘤与高FDG摄取显著相关,准确认识这些因素有助于降低误诊率。
研究设计与样本
- 回顾性分析58例经手术或活检证实的良性孤立性神经鞘瘤的PET/CT、增强CT及病理结果,评估各变量与SUVmax的关联。
关键影像表现/征象
- 58例良性神经鞘瘤SUVmax为4.1±2.1(范围1.5-11.1)。
- 按部位分为胃肠道/心脏/腹盆腔/胸壁(1型部位)与其他部位(2型部位),1型部位SUVmax 5.8±2.4,2型部位3.3±1.5(p=0.000)。
- 7例见瘤周淋巴细胞套,其中4例为胃肠道来源,占胃肠道神经鞘瘤的80%(4/5)。
- 7例瘤周淋巴细胞套中5例伴瘤周淋巴结增大。
- 强化程度与SUVmax显著相关(r=0.556,p=0.000)。
诊断标准与关键数值
- 肿瘤部位与SUVmax显著相关(r=0.538,p=0.000)。
- 瘤周淋巴细胞套与SUVmax显著相关(r=0.456,p=0.000)。
- 肿瘤部位与瘤周淋巴细胞套存在显著相关(r=0.640,p=0.000)。
- 强化程度与SUVmax显著相关(r=0.556,p=0.000)。
临床应用与阅片要点
- 良性孤立性神经鞘瘤可表现为高FDG摄取,位于胃肠道/心脏/腹盆腔/胸壁、伴瘤周淋巴细胞套或中至显著强化者更易出现高摄取。
- 瘤周淋巴细胞套与瘤周淋巴结增大相关,阅片时需注意识别。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Imaging features of positron emission tomography (PET)/computed tomography (CT) and contrast-enhanced CT and pathological changes in benign solitary schwannoma were retrospectively analyzed, and the factors associated with high uptake of fluorodeoxyglucose (FDG) were examined.
METHODS: The PET/CT, contrast-enhanced CT, and pathological results of 58 cases of benign solitary schwannomas confirmed by surgery or biopsy were retrospectively analyzed. The association of each variable with the maximum standardized uptake value (SUVmax) was evaluated.
RESULTS: The SUVmax of the 58 benign schwannoma cases was 4.1 ± 2.1 (1.5-11.1). When the locations of schwannomas were divided into gastrointestinal system/heart/abdominal and pelvic cavities/thoracic wall (type-1 locations) and other sites (type-2 locations), the schwannoma location was significantly correlated with the SUVmax (r = 0.538, p = 0.000). The SUVmax values were 5.8 ± 2.4 and 3.3 ± 1.5, respectively (p = 0.000). Peritumoral lymphoid cuffs were observed in 7 cases, 4 of which were tumors of gastrointestinal origin, accounting for 80 % of the gastrointestinal schwannomas (4/5). The presence of peritumoral lymphoid cuffs was significantly correlated with the SUVmax (r = 0.456, p = 0.000). The location of the schwannoma was significantly correlated with the presence of peritumoral lymphoid cuffs (r = 0.640, p = 0.000). We found that a peritumoral lymphoid cuff is strongly correlated with the presence of regional lymphadenopathy. Among the 7 cases showing peritumoral lymphoid cuffs, 5 cases had the presence of peritumoral enlarged lymph nodes. The degree of enhancement was significantly correlated with the SUVmax (r = 0.556, p = 0.000).
CONCLUSIONS: Benign schwannomas originating from the gastrointestinal system/heart/abdominal location and showing the presence of peritumoral lymphoid cuffs or moderate and significant enhancement on contrast-enhanced CT were significantly associated with high FDG uptake. An accurate understanding of the factors associated with high FDG uptake can help reduce the misdiagnosis rate.
引用
- Wang SY, Liu JH, Yao S, et al. PET/CT and contrast-enhanced CT imaging findings in benign solitary schwannomas. Eur J Radiol. 2021. PMID: 34139574. doi:10.1016/j.ejrad.2021.109820
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。